$38.91
Quidel Corporation is a medical devices business based in the US. Quidel Corporation shares (QDEL) are listed on the NASDAQ and all prices are listed in US Dollars. Quidel Corporation employs 7,100 staff and has a trailing 12-month revenue of around $2.9 billion.
Our top picks for where to buy Quidel Corporation stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- No-cost financial planning and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Quidel Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – QDEL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Quidel Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Quidel Corporation stock price (NASDAQ: QDEL)
Use our graph to track the performance of QDEL stocks over time.Quidel Corporation shares at a glance
Latest market close | $38.24 |
---|---|
52-week range | $29.74 - $89.11 |
50-day moving average | $38.04 |
200-day moving average | $53.85 |
Wall St. target price | $54.60 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-26.38 |
Is it a good time to buy Quidel Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Quidel Corporation price performance over time
Historical closes compared with the close of $38.24 from 2024-07-25
1 week (2024-07-19) | 10.23% |
---|---|
1 month (2024-06-26) | 13.27% |
3 months (2024-04-26) | -3.53% |
6 months (2024-01-26) | -45.65% |
1 year (2023-07-26) | -56.67% |
---|---|
2 years (2022-07-25) | -62.64% |
3 years (2021-07-26) | 139.73 |
5 years (2019-07-26) | 58.86 |
Is Quidel Corporation stock undervalued or overvalued?
Valuing Quidel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quidel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quidel Corporation's PEG ratio
Quidel Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quidel Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quidel Corporation's EBITDA
Quidel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $620.3 million.
The EBITDA is a measure of a Quidel Corporation's overall financial performance and is widely used to measure a its profitability.
Quidel Corporation financials
Revenue TTM | $2.9 billion |
---|---|
Operating margin TTM | 2.32% |
Gross profit TTM | $1.9 billion |
Return on assets TTM | 1.32% |
Return on equity TTM | -42.51% |
Profit margin | -61.65% |
Book value | $49.52 |
Market Capitalization | $2.3 billion |
TTM: trailing 12 months
Quidel Corporation share dividends
We're not expecting Quidel Corporation to pay a dividend over the next 12 months.
Quidel Corporation share price volatility
Over the last 12 months, Quidel Corporation's shares have ranged in value from as little as $29.735 up to $89.11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quidel Corporation's is 0.067. This would suggest that Quidel Corporation's shares are less volatile than average (for this exchange).
Quidel Corporation overview
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use.
Frequently asked questions
What percentage of Quidel Corporation is owned by insiders or institutions?Currently 1.426% of Quidel Corporation shares are held by insiders and 95.331% by institutions. How many people work for Quidel Corporation?
Latest data suggests 7,100 work at Quidel Corporation. When does the fiscal year end for Quidel Corporation?
Quidel Corporation's fiscal year ends in December. Where is Quidel Corporation based?
Quidel Corporation's address is: 9975 Summers Ridge Road, San Diego, CA, United States, 92121 What is Quidel Corporation's ISIN number?
Quidel Corporation's international securities identification number is: US74838J1016 What is Quidel Corporation's CUSIP number?
Quidel Corporation's Committee on Uniform Securities Identification Procedures number is: 74838J101
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question